CA2335079C - Composition for the treatement of immune deficiencies and methods for its preparation and use - Google Patents

Composition for the treatement of immune deficiencies and methods for its preparation and use Download PDF

Info

Publication number
CA2335079C
CA2335079C CA002335079A CA2335079A CA2335079C CA 2335079 C CA2335079 C CA 2335079C CA 002335079 A CA002335079 A CA 002335079A CA 2335079 A CA2335079 A CA 2335079A CA 2335079 C CA2335079 C CA 2335079C
Authority
CA
Canada
Prior art keywords
afp
aap
complex according
reversible complex
equilibrium reversible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002335079A
Other languages
English (en)
French (fr)
Other versions
CA2335079A1 (en
Inventor
Oleg Strelchenok
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ardenia Investments Ltd
Original Assignee
Ardenia Investments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ardenia Investments Ltd filed Critical Ardenia Investments Ltd
Publication of CA2335079A1 publication Critical patent/CA2335079A1/en
Application granted granted Critical
Publication of CA2335079C publication Critical patent/CA2335079C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002335079A 1998-06-17 1999-06-17 Composition for the treatement of immune deficiencies and methods for its preparation and use Expired - Fee Related CA2335079C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9802162-9 1998-06-17
SE9802162A SE9802162D0 (sv) 1998-06-17 1998-06-17 Immunostimulating composition
PCT/EP1999/004201 WO1999065936A2 (en) 1998-06-17 1999-06-17 Composition for the treatement of immune deficiencies and methods for its preparation and use

Publications (2)

Publication Number Publication Date
CA2335079A1 CA2335079A1 (en) 1999-12-23
CA2335079C true CA2335079C (en) 2008-01-08

Family

ID=20411743

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002335079A Expired - Fee Related CA2335079C (en) 1998-06-17 1999-06-17 Composition for the treatement of immune deficiencies and methods for its preparation and use

Country Status (10)

Country Link
US (1) US6599507B2 (enExample)
EP (1) EP1085909B1 (enExample)
JP (1) JP4392991B2 (enExample)
AT (1) ATE314094T1 (enExample)
AU (1) AU748838B2 (enExample)
BR (1) BR9911294B1 (enExample)
CA (1) CA2335079C (enExample)
DE (1) DE69929189T2 (enExample)
SE (1) SE9802162D0 (enExample)
WO (1) WO1999065936A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802162D0 (sv) 1998-06-17 1998-06-17 Nomet Management Services Bv Immunostimulating composition
SE9900941D0 (sv) * 1998-12-23 1999-03-16 Nomet Management Serv Bv Novel retinoic acid derivatives and their use
ATE243701T1 (de) * 1999-03-16 2003-07-15 Ardenia Investments Ltd Polyungesättigte fettsäurederivate und deren verwendung in der krebsbehandlung
WO2002004467A1 (en) * 2000-07-12 2002-01-17 Ardenia Investments Ltd. Novel cytotoxic compounds and their use
US20070111936A1 (en) * 2005-11-15 2007-05-17 Vladimir Pak Complex of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096863A (en) * 1996-08-23 2000-08-01 Regents Of The University Of Minnesota Self-assembling amphiphiles for construction of peptide secondary structures
SE9802162D0 (sv) 1998-06-17 1998-06-17 Nomet Management Services Bv Immunostimulating composition

Also Published As

Publication number Publication date
EP1085909A2 (en) 2001-03-28
EP1085909B1 (en) 2005-12-28
US6599507B2 (en) 2003-07-29
WO1999065936A3 (en) 2000-02-10
BR9911294B1 (pt) 2012-01-10
HK1035866A1 (en) 2001-12-14
BR9911294A (pt) 2002-01-02
AU748838B2 (en) 2002-06-13
SE9802162D0 (sv) 1998-06-17
JP2004500315A (ja) 2004-01-08
CA2335079A1 (en) 1999-12-23
WO1999065936A2 (en) 1999-12-23
JP4392991B2 (ja) 2010-01-06
AU4773499A (en) 2000-01-05
DE69929189T2 (de) 2006-08-31
DE69929189D1 (de) 2006-02-02
ATE314094T1 (de) 2006-01-15
US20010034324A1 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
Weinstein et al. Membranes of animal cells: VI. The glycolipids of the L cell and its surface membrane
CA2215339C (en) Immunomodulating compositions from bile for the treatment of immune system disorders
EP0717631B1 (en) Immunomodulating compositions from bile
CN118203658A (zh) 一种重组抗Claudin18.2全人源单克隆抗体注射液制剂及制备方法
CA2335079C (en) Composition for the treatement of immune deficiencies and methods for its preparation and use
CN107760661A (zh) 药用激肽原酶的peg修饰物及其制备方法和应用
Slepnev et al. Fatty acid acylated peroxidase as a model for the study of interactions of hydrophobically-modified proteins with mammalian cells
RU2205010C2 (ru) Природные противоопухолевые или противовирусные вещества и их применение
Bodenheimer Jr et al. Characterization of a new monoclonal antibody to rat macrophages and Kupffer cells
US4129648A (en) Method for reducing endogenous prostaglandin synthesis
JPS63246339A (ja) 親油性有効成分のリポタンパク質への取り込み方法、そのリポタンパク質および医薬組成物
Rebbaa et al. Distribution of exogenously added gangliosides in serum proteins depends on the relative affinity of albumin and lipoproteins.
HK1035866B (en) A complex of alpha-fetoprotein (afp) and a polyunsaturated fatty acid derivative for the treatment of immune deficiencies
US20040101569A1 (en) Immunomodulating compositions from bile
SK67596A3 (en) Hirudin conjugates from hirudine and lipophilic compounds
Gulevskyy et al. CURRENT CONCEPT OF THE STRUCTURAL AND FUNCTIONAL PROPERTIES OF ALFA-FETOPROTEIN AND THE POSSIBILITIES OF ITS CLINICAL APPLICATION
MXPA00012558A (en) Composition for the treatement of immune deficiencies and methods for its preparation and use
Bullier-Picard et al. In-vivo uptake of human growth hormone in male rat liver
JP3648717B2 (ja) 難溶性生理活性物質を細胞内に導入するための混合溶媒
TAKEMURA-HATTORI et al. Depression of macrophage function by lipoprotein from tumorous ascites
Kobanenko et al. Plasma Protein Adsorption on Melphalan Prodrug Bearing Liposomes-Bare, Stealth, and Targeted
Katayama et al. Antibody-mediated rosette formation of epidermal cells with leukocytes in pemphigus vulgaris
Steinbeck et al. Molecular events in gamma interferon-induced activation of bovine neutrophils
AU9724298A (en) Immunomodulation compositions from bile
HK1007922B (en) Immunomodulating compositions from bile

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20190617